The aim of the present study was to investigate the effects of curcumin and Tetra Hydro Curcumin (THC) on the inhibition of endothelium-dependent vasorelaxation of the isolated rat aorta by Homocysteine Thiolactone (HTL). Carbachol, an endothelium-dependent vasodilator, caused concentration-dependent vasorelaxation in rat aortic rings. Exposure of aortic rings to HTL (0.3 and 1 mM) for 90 min significantly inhibited endothelium-dependent vasorelaxation to carbachol. In addition, contractions induced by methoxamine were significantly reduced after pretreatment with 3 mM HTL. Curcumin (10 and 30 μM) significantly restored carbachol-induced vasorelaxation inhibited by HTL (1 mM). Similar effects were observed after pretreatment of aortic rings with THC (10 and 30 μM). Moreover, HTL-induced impairment of vasorelaxation to carbachol could be blocked by either L-arginine (3 mM), a precursor of nitric oxide or superoxide dismutase (SOD, 200 U mL-1), a scavenger of superoxide anion. These results demonstrate that impairment of endothelium-dependent vasorelaxation induced by HTL is due to a reduction of nitric oxide and the generation of oxygen free radicals. Interestingly, curcumin and THC could restore endothelial dysfunction induced by HTL which may be related to their antioxidant properties. The present study provides pharmacological data to support the hypothesis that curcumin and THC have vasoprotective effects in hyperhomocysteinemia.
PDF Abstract XML References Citation
How to cite this article
Homocysteine, a sulfur-containing amino acid, is an intermediate product in metabolism of L-methionine. Deficiencies of vitamin B12 and folate cause an increase in plasma level of homocysteine, termed as hyperhomocysteinemia (Alshatwi, 2007). Hyperhomocysteinemia is a powerful independent risk factor for various cardiovascular disease such as atherosclerosis, hypertension, myocardial infarction (Balakumar et al., 2007; Joshaghani et al., 2007; Laghari et al., 2009; Ravari et al., 2009; Damorou et al., 2010; Williams and Schalinske, 2010). In fact, homocysteine acts as a pro-thrombotic, pro-inflammatory and vasorelaxation-imparing factor (Perla-Kajan et al., 2007). Several studies have shown that endothelium-dependent vasorelaxations are impaired in animals and human with hyperhomocysteinemia (Ungvari et al., 1999; Boger et al., 2000; Tawakol et al., 1997; Abahji et al., 2007).
There is evidence that Homocysteine Thiolactone (HTL), a homocysteine-reactive product, is involved in vascular damage due to homocysteine (Jakubowski, 2008; Karolczak and Olas, 2009). Protein N-homocysteinylation induced by HTL may lead to cardiovascular disorders (Karolczak and Olas, 2009). Incubation of rat aortic rings with HTL causes an impairment of endothelium-dependent vasorelaxation (Liu et al., 2007). The endothelial dysfunctions induced by HTL involve a decreased release of nitric oxide from endothelial cells and increased generation of reactive oxygen species (Liu et al., 2007; Jakubowski, 2008; Karolczak and Olas, 2009).
Curcumin (diferuloylmethane) is a phenolic compound from the plant Curcuma longa or turmeric. Commonly, it is used as a spices and coloring agent (Srivastava et al., 2011). Pharmacological studies have demonstrated that curcumin has a variety of effects, including antispasmodic (Itthipanichpong et al., 2003), antidepressant (Yu et al., 2002), anti-oxidant (Manikandan et al., 2004; Hussein and Abu-Zinadah, 2010; Sivabalan and Anuradha, 2010), antibacterial (Negi et al., 1999; Pandey et al., 2011), anti-inflammatory (Kohli et al., 2005; Yuan et al., 2006), anticarcinogenic (Yoysungnoen et al., 2008), antinociceptive (Tajik et al., 2007) Schistosomicidal properties (EL-Sherbiny et al., 2006). Moreover, curcumin could lower plasma level of glucose (Sivabalan and Anuradha, 2010). In addition, curcumin could restore endothelial dysfunction (Ramaswami et al., 2004). Recent studies in diabetic rats have shown that tetrahydrocurcumin, an active metabolite of curcumin, has anti-oxidant (Murugan and Pari, 2006a), anti-diabetic (Murugan and Pari, 2006b) and anti-hyperlipidemic effects (Pari and Murugan, 2007). However, curcumin and THC have not been studied in endothelial dysfunction induced by HTL. Thus, the aim of this study was to investigate the effects of curcumin and THC against endothelial dysfunction induced by HTL and mechanisms involved in their actions in the isolated rat aorta.
MATERIALS AND METHODS
Chemicals: All drugs and chemicals were purchased from Sigma Chemical Company (St. Louis, Missouri, USA) but zoletil was purchased from Virbac (Carros Cedex, France). Curcumin and THC were prepared by our laboratory. All drugs were dissolved in the Krebs solution, except curcumin and THC were dissolved in dimethyl sulphoxide.
Extraction of curcumin and tetrahydrocurcumin: The mixture of curcuminoid extracted from the rhizomes of Curcuma longa was subjected to silica gel column chromatography, using hexane-dichloromethane, dichloromethane and dichloromethane-methanol as eluents to yield curcumin, the major compound. THC was synthesized from curcumin as described by Yoysungnoen et al. (2008). Structures of curcumin and THC were shown in Fig. 1.
|Fig. 1:||Structures of curcumin and tetrahydocurcumin|
Tissue preparation: In 2010, experiments were performed using aorta obtained from male Wistar rats (300-350 g) bred and kept by the National Laboratory Animal Center, Mahidol University, Thailand. The rats were fed with standard laboratory rat chow and tap water and housed in standard environmental condition (25°C) under 12 h light/dark cycles. All experiments were reviewed and approved by the Animal Research Ethics Committee of the Faculty of Medicine, Srinakharinwirot University.
The rats were anaesthetized with zoletil 50 mg kg-1 (tiletamine chloridrate and zolazepan chloridrate). Into quadriceps muscle and killed by cervical dislocation (Tep-areenan and Sawasdee, 2011). Following a thoracotomy, the thoracic aorta was dissected from the rat. The aorta was cleaned of fat and connective tissue and cut into 4-5 mm ring segments. Each ring was mounted between two stainless wires and then transferred to a jacketed organ bath filled with 20 ml of modified Krebs-Henseleit solution (composition, mM; NaCl 118, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25, CaCl2 2, D-glucose 10) that was maintained at 37°C and bubbled continuously with 95% O2 and 5% CO2 mixture. The buffer in the organ bath was exchanged every 15 min for 1 h. The rings were mounted between two triangular stainless steel hooks that were passed through the lumen and stretched to an optimal passive tension of about 1 g and then allowed to equilibrate for 60 min before experiments were started. Tension was measured by isometric force transducers (MLT 0210) connected to a MacLab recording system (AD instruments, New South Wales, Australia).
Experimental protocol: Following a 1 h equilibration period, aortic rings of control were incubated with vehicle (distilled water) and the rings of HTL groups were incubated with HTL (0.3 and 1 mM) for 90 min. After 90 min of incubation, methoxamine, an alpha adrenoceptor agonist, was used to increase vascular tone by approximately 1 g. Once a stable tone was achieved, concentration-response curves of carbachol (1 nM-100 μM) were constructed.
To investigate the effects of HTL on contractions induced by methoxamine, after aortic rings were allowed to equilibrate for 1 h at 1 g tension, aortic rings were incubated with vehicle or HTL (0.3 to 30 mM) for 90 min. After incubation period of 90 min, methoxamine (0.1-300 μM) was added cumulatively in the bath.
To investigate the effects of antioxidants, curcumin and THC, on impairment of endothelium-dependent relaxation induced by HTL, curcumin (10 and 30 μM) and THC (10 and 30 μM), were co-incubation with 1 mM HTL for 90 min. In addition, the effects of L-arginine, a precursor of nitric oxide (NO) and SOD, a scavenger of superoxide anion, on inhibition of HTL were investigated. L-arginine (3 mM) and SOD (200 U mL-1) were co-incubation with 1 mM HTL for 90 min. This concentration of HTL was used as methoxamine could not induce tone after incubation of aortic rings with a higher concentration (3 mM) of HTL. After incubation of 90 min, tone was induced by addition of methoxamine. Then, concentration-response curves of carbachol were constructed.
Statistical analysis: The concentration of vasorelaxant giving half-maximal relaxation (EC50) and maximal responses (Rmax) were obtained from the concentration-response curve fitted to a sigmoidal logistic equation using the GraphPad Prism package as described by Tep-areenan et al. (2003). Rmax and pEC50 values (negative logarithm of the EC50) were compared by analysis of variance (ANOVA) with statistically significant differences between groups being determined by Bonferronis post-hoc test. Results are expressed as mean+SE. A value of p<0.05 was considered statistical significant. The number of animals in each group is represented by n (Tep-areenan and Sawasdee, 2011).
Effects of HTL on relaxation and contraction of rat aortic rings: In Fig. 2, contractions induced by 30 μM methoxamine were significantly (p<0.001) inhibited in rings incubated with 3 mM HTL (Rmax: control = 1.04±0.15 g, n = 6; 3 mM HTL = 1.04±0.15 g, n = 6) but not 0.3 and 1 mM HTL.
|Fig. 2:||Effects of pre-treatment with homocysteine thiolactone (0.3 to 3 mM) for 90 min on contractions to methoxamine (30 μM) in rat aortic rings. Data are shown as Mean±SEM ***Significantly different at p<0.001|
In addition, 10 aortic mM or 30 mM of HTL completely inhibited methoxamine-induced contraction (data not shown).
Carbachol caused concentration-dependent relaxation (Rmax = 101±3% with EC50 = 6.24±0.08, n = 6). Endothelium-dependent vasorelaxations to carbachol were significantly (p<0.001) reduced after incubation of aortic rings with HTL (0.3 and 1 mM) (Rmax: control = 101±3%, n = 6; 0.3 mM HTL = 77.1±3.4%, n = 6; 1 mM HTL = 52.6±3.2%, n = 6, Fig. 3).
Effects of curcumin and THC on endothelium-dependent vasorelaxation to carbachol in rat aortic rings: Treatment of aortic rings with curcumin in different concentrations (10 and 30 μM) significantly (p<0.001) prevented the inhibitory effects of HTL (1 mM) on relaxant responses to carbachol (Rmax: control = 101±3%, n = 6; 1 mM HTL = 52.6±3.2%, n = 6; 10 μM curcumin = 80.7±3.4%, n = 6; 30 μM curcumin = 80.9±3.5%, n = 6; Fig. 4).
|Fig. 3:||Effects of pre-treatment with homocysteine thiolactone (0.3 and 1 mM HTL) for 90 min on carbachol-induced vasorelaxation in rat aortic rings. Data are shown as Mean±SEM|
|Fig. 4:||Effects of pre-treatment with homocysteine thiolactone (HTL 1 mM) for 90 min on carbachol-induced vasorelaxation in the presence of 10 and 30 μM curcumin (C) in rat aortic rings. Data are shown as Mean±SEM|
|Fig. 5:||Effects of pre-treatment with homocysteine thiolactone (HTL 1 mM) for 90 min on carbachol-induced vasorelaxation in the presence of 10 and 30 μM tetrahydrocurcumin (THC) in rat aortic rings. Data are shown as Mean±SEM|
|Fig. 6:||Effects of pre-treatment with homocysteine thiolactone (HTL 1 mM) for 90 min on carbachol-induced vasorelaxation in the presence of L-arginine (3 mM) and SOD (200 U mL-1) in rat aortic rings. Data are shown as Mean±SEM|
Similarly, THC (10 and 30 μM) significantly (p<0.001) restored impairment of relaxation to carbachol after treatment with HTL (1 mM) (Rmax: control = 101±3%, n = 6; 1 mM HTL = 52.6±3.2%, n = 6; 10 μM THC = 85.1±3.5%, n = 6; 30 μM THC = 93.5±3.9%, n = 6; Fig. 5). However, there was no significant difference of the protective effects between curcumin and THC.
Effects of L-arginine and SOD on endothelium-dependent vasorelaxation to carbachol in rat aortic rings: As shown in Fig. 6, co-incubation of L-arginine (3 mM) or SOD (200 U mL-1) in the presence of HTL (1 mM) significantly restored carbachol-induced vasorelaxation (Rmax: control = 101±3%, n=6; 1 mM HTL = 52.6±3.2%, n = 6; L-arginine = 109±3%, n = 6; SOD = 108±4%, n = 6).
The present study in rat aortic rings demonstrated that HTL inhibited endothelium-dependent vasorelaxation to carbachol and contraction to methoxamine, an alpha adrenoceptor agonist. Interestingly, this is the first time that curcumin and THC have been shown to restore HTL-induced impairment of endothelium-dependent vasorelaxation.
Hyperhomocysteinemia is though to induce arteriosclerosis and peripheral vascular disease which cause dysfunctions of endothelial cells (Abahji et al., 2007; Jakubowski, 2008). In the present study, we showed that exposure of aortic rings to HTL (1 mM) caused a significant attenuation of endothelium-dependent vasorelaxation to carbachol. Theses findings are consistent with other studies in isolated animal vessels (Fu et al., 2003; Ramaswami et al., 2004; Liu et al., 2007). In addition, a high concentration of HTL (3 mM) reduced contraction to methoxamine, alpha 1-adrenoceptor agonist. These results suggest that HTL may affect the mechanisms involved in methoxamine-induced contraction, including activation of protein kinase C to increase extracellular Ca2+ influx through receptor-operated Ca2+ channels and/or Ca2+ release from intracellular store (Burt et al., 1996; Lyles et al., 1998).
Impairment of endothelial functions induced by homocysteine and HTL, a homocysteine-reactive product, involves an increase in the formation of oxygen free radicals, especially superoxide anion and lipid peroxidation products (Zappacosta et al., 2001; Fu et al., 2003; Ramaswami et al., 2004; Jakubowski, 2008). In agreement with previous reports, the present study showed that SOD, a scavenger of superoxide anion, inhibited impairment of endothelium-dependent relaxation induced by HTL in rat aortic rings.
Superoxide anions are known to inhibit endothelium-dependent relaxation by inactivating endothelium-dependent relaxing factors, mainly NO (Mercie et al., 2000). Indeed, our results showed that impairment of relaxation induced by HTL are restored after pretreatment with L-arginine, a precursor of No. These results suggest that endothelial dysfunctions caused by HTL are likely to increase NO degradation by oxygen free radicals and/or decreasing endothelium-derived NO synthesis.
We then investigate the effects of curcumin and its active metabolite, THC, on endothelial dysfunctions induced by HTL. We found that curcumin reverse impairment of endothelium-dependent relaxation induced by HTL in rat aortic rings. These results are in agreement with a previous study showing that curcumin could restore endothelial dysfunctions induced by homocysteine in porcine coronary arteries (Ramaswami et al., 2004). Interestingly, we found that THC had similar effects. From the present findings, it is suggested that vasoprotective effects of both curcumin and THC may involve their antioxidant property (Manikandan et al., 2004; Murugan and Pari, 2006a; Hussein and Abu-Zinadah, 2010; Sivabalan and Anuradha, 2010). These findings are supported by a recent study showing that curcumin reduced production of superoxide anion in porcine coronary arteries. Moreover, curcumin increase endothelial nitric oxide synthase in porcine coronary arteries (Ramaswami et al., 2004). Taken together, mechanisms of the inhibitory effects of curcumin and THC on HTL-induced endothelial dysfunctions may involve decreasing of superoxide anion and increasing production of No. These may constitute significant mechanisms of cardioprotection by curcumin and its metabolite, THC.
These findings demonstrate that curcumin and THC effectively reverse endothelial dysfunction induced by HTL which may be related to scavenging oxygen free radicals and enhancing NO production. The present findings provide pharmacological evidence for mechanisms contributing to vasoprotective effects of curcumin and THC in hyperhomocysteinemia. However, further investigation would need to be pursued to examine other mechanisms including the interaction between THC and HTL.
This study was funded by The Faculty of Medicine, Srinakharinwirot University (Grant No. 084/2552). We would like to express our deepest gratitude to Dr. Alfredo Villarroel for improving the English. We also thank Mr. Phongphat Wetchasit for his technical support. The authors have no conflict of interest to report.
- Abahji, T.N., L. Nill, N. Ide, C. Keller, U. Hoffmann and N. Weiss, 2007. Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction. Arch. Med. Res., 38: 411-416.
- Alshatwi, A.A., 2007. Vitamin B12 and folate deficiencies and hyperhomocysteinemia in elderly. J. Med. Sci., 7: 402-407.
- Balakumar, P., A.P. Singh, S.S. Ganti and M. Singh, 2007. Hyperhomocysteinemia and cardiovascular disorders: Is there a correlation? Trends Med. Res., 2: 160-166.
- Boger, R.H., S.M. Bode-Boger, K. Sydow, D.D. Heistad and S.R. Lentz, 2000. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol., 20: 1557-1564.
- Burt, R.P., C.R. Chapple and I. Marshall, 1996. The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens. Br. J. Pharmacol., 117: 224-230.
- Damorou, F., T. Tcherou, K. Yayehd, S. Pessinaba and I.B. Diop, 2010. Homocysteine level and cardiovascular afflictions in the black african patients in lome. Res. J. Cardiol., 3: 1-8.
- EL-Sherbiny, M., M.M. Abdel-Aziz, K.A. Elbakry, E.A. Toson and A.T. Abbas, 2006. Schistosomicidal effect of curcumin. Trends Applied Sci. Res., 1: 627-633.
- Fu, Y.F., Y. Xiong and S.H. Fu, 2003. Captopril restores endothelium-dependent relaxation of rat aortic rings after exposure to homocysteine. J. Cardiovasc. Pharmacol., 42: 566-572.
- Hussein, H.K. and O.A. Abu-Zinadah, 2010. Antioxidant effect of curcumin extracts in induced diabetic Wister rats. Int. J. Zool. Res., 6: 266-276.
- Itthipanichpong, C., N. Ruangrungsi, W. Kemsri and A. Sawasdipanich, 2003. Antispasmodic effects of curcuminoids on isolated guinea-pig ileum and rat uterus. J. Med. Assoc. Thai., 86: S299-S309.
- Jakubowski, H., 2008. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J. Physiol. Pharmacol., 59: 155-167.
- Joshaghani, H.R., A.A. Shirafkan and A. Marjani, 2007. Serum homocysteine levels in patients with myocardial infarction in Gorgan (in Northern Iran). Asian J. Biochem., 2: 157-160.
- Karolczak, K. and B. Olas, 2009. Mechanism of action of homocysteine and its thiolactone in hemostasis system. Physiol. Res., 58: 623-633.
- Kohli, K., J. Ali, M.J. Ansari and Z. Raheman, 2005. Curcumin: A natural anti-inflammatory agent. Indian J. Pharmacol., 37: 141-147.
- Laghari, A.H., A.N. Memon, A.M. Shah, S.F. Ahmed and M.S. Memon, 2009. Hyperhomocysteinemia, a risk factor for myocardial infarction in patients with type-2 diabetes in Southern Sindh, Pakistan. Pak. J. Nutr., 8: 1753-1755.
- Liu, Y.H., Y. You, T. Song, S.J. Wu and L.Y. Liu, 2007. Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril. J. Cardiovasc. Pharmacol., 50: 155-161.
- Lyles, G.A., C. Birrell, G. Banchelli and R. Pirisino, 1998. Amplification of alpha 1D-adrenoceptor mediated contractions in rat aortic rings partially depolarized with KCl. Pharmacol. Res., 37: 437-454.
- Mercie, P., O. Garnier, L. Lascoste, M. Renard and C. Closse et al., 2000. Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis, 5: 403-411.
- Murugan, P. and L. Pari, 2006. Antioxidant effect of tetrahydrocurcumin in Streptozotocin-nicotinamide induced diabetic rats. Life Sci., 79: 1720-1728.
- Murugan, P. and L. Pari, 2006. Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats. Basic Clin. Pharmacol. Toxicol., 99: 122-127.
- Negi, P.S., G.K. Jayaprakasha, L.J.M. Rao and K.K. Sakariah, 1999. Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J. Agric. Food. Chem., 47: 4297-4300.
- Pandey, A., R.K. Gupta, A. Bhargava and B. Agrawal, 2011. Antibacterial activities of curcumin bioconjugates. Int. J. Pharmacol., 7: 874-879.
- Pari, L. and P. Murugan, 2007. Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Renal Failure, 29: 881-889.
- Perla-Kajan, J., T. Twardowski and H. Jakubowski, 2007. Mechanisms of homocysteine toxicity in humans. Amino Acids, 32: 561-572.
- Ramaswami, G., H. Chai, Q. Yao, P.H. Lin, A.B. Lumsden and C. Chen, 2004. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J. Vasc. Surg., 40: 1216-1222.
- Ravari, H., M.R. Zafarghandi, D. Alvandfar and S. Saadat, 2009. Serum homocysteine in deep venous thrombosis, peripheral atherosclerosis and healthy Iranians: A case-control study. Pak. J. Biol. Sci., 12: 1019-1024.
- Pandey, A., R.K. Gupta and R. Srivastava, 2011. Curcumin-the yellow magic. Asian J. Applied Sci., 4: 343-354.
- Sivabalan, S. and C.V. Anuradha, 2010. A comparative study on the antioxidant and glucose-lowering effects of curcumin and bisdemethoxycurcumin analog through in vitro assays. Int. J. Pharmacol., 6: 664-669.
- Tajik, H., E. Tamaddonfard and N. Hamzeh-Gooshchi, 2007. Interaction between curcumin and opioid system in the formalin test of rats. Pak. J. Biol. Sci., 10: 2583-2586.
- Tep-Areenan, P. and P. Sawasdee, 2011. The vasorelaxant effects of Anaxagorea luzonensis A. Grey in the rat Aorta. Int. J. Pharmacol., 7: 119-124.
- Ungvari, Z., P. Pacher, K. Rischak, L. Szollar and A. Koller, 1999. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol., 19: 1899-1904.
- Williams, K.T. and K.L. Schalinske, 2010. Homocysteine metabolism and its relation to health and disease. Biofactors, 36: 19-24.
- Yoysungnoen, P., P. Wirachwong, C. Changtam, A. Suksamrarn and S. Patumraj, 2008. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J. Gastroenterol., 14: 2003-2009.
- Yu, Z.F., L.D. Kong and Y. Chen, 2002. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J. Ethnopharmocol., 83: 161-165.
- Yuan, G., M.L. Wahlqvist, G. He, M. Yang and D. Li, 2006. Natural products and anti-inflammatory activity. Asia Pac. J. Clin. Nutr., 15: 143-152.
- Zappacosta, B., A. Mordente, S. Persichilli, A. Minucci and P. Carlino et al., 2001. Is homocysteine a pro-oxidant?. Free Radic. Res., 35: 499-505.